Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Cancer Detection and Prevention|April 2, 1999
Subcutaneous administration of interleukin-2 and interferon-alpha 2b in advanced renal cell carcinoma: long-term resultsM C Locatelli, G Facendola, G Pizzocaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2013
Modified cisplatin, etoposide, and ifosfamide (PEI) salvage therapy for male germ cell tumors: long-term efficacy and safety outcomesA Necchi, N Nicolai, L Mariani, et al.
Chemistry and Physics of Lipids|July 3, 2021
Cineole-containing nanoemulsion: Development, stability, and antibacterial activityTayonara S Lima, Maria Fátima S Silva, Xirley P Nunes, et al.
European Urology|January 1, 1983
Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trialG Pizzocaro, G Di Fronzo, L Piva, et al.
British Journal of Cancer|May 19, 2005
Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatmentR Luksch, M Podda, L Gandola, et al.
Neurology|December 24, 2010
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophyE Pegoraro, E P Hoffman, L Piva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2014
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomesP Giannatempo, T Greco, L Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 26, 2014
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II studyA Necchi, L Mariani, M Di Nicola, et al.
BMJ Supportive & Palliative Care|June 2, 2016
Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality researchM J Hjermstad, N Aass, F Aielli, et al.
Pageof 7